266. Ceftriaxone Versus Cefazolin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia

BACKGROUND: Few studies have evaluated the use of ceftriaxone (CRO) in the treatment of Methicillin-sensitive Staphylococcus aureus (MSSA) infections. Available studies include a small number of patients with MSSA bacteremia, with conflicting results and several limitations. The purpose of this stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohamed, Adham, Bennett, Nick, Ploetz, Jeannette, Aragon, Laura, Kennedy, Kevin, Boyd, Sarah E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777830/
http://dx.doi.org/10.1093/ofid/ofaa439.310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777830/
http://dx.doi.org/10.1093/ofid/ofaa439.310

Ejemplares similares